HCP (NYSE:HCP) Hits New 12-Month High at $32.29
HCP, Inc. (NYSE:HCP) reached a new 52-week high during trading on Friday . The stock traded as high as $32.29 and last traded at $32.28, with a volume of 19376 shares traded. The stock had previously closed at $31.94.
Several equities research analysts have recently commented on the stock. Zacks Investment Research raised shares of HCP from a “sell” rating to a “hold” rating in a research report on Thursday, March 14th. Morgan Stanley set a $32.00 target price on shares of HCP and gave the stock a “hold” rating in a research report on Thursday, March 28th. TheStreet cut shares of HCP from a “b-” rating to a “c+” rating in a research report on Tuesday, May 7th. Finally, Raymond James raised shares of HCP from a “market perform” rating to an “outperform” rating and set a $35.00 price target for the company in a research report on Thursday. Four equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average target price of $30.05.
The firm has a market capitalization of $15.27 billion, a PE ratio of 17.80, a PEG ratio of 6.88 and a beta of 0.32. The company has a quick ratio of 0.80, a current ratio of 0.80 and a debt-to-equity ratio of 0.90.
The company also recently announced a quarterly dividend, which was paid on Tuesday, May 21st. Shareholders of record on Monday, May 6th were issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a yield of 4.59%. The ex-dividend date of this dividend was Friday, May 3rd. HCP’s dividend payout ratio (DPR) is presently 81.32%.
In other news, Director Christine Garvey sold 3,405 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $29.80, for a total value of $101,469.00. Following the completion of the transaction, the director now owns 5,348 shares in the company, valued at approximately $159,370.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.13% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in HCP. Vanguard Group Inc raised its position in shares of HCP by 0.3% in the third quarter. Vanguard Group Inc now owns 75,247,949 shares of the real estate investment trust’s stock valued at $1,980,527,000 after buying an additional 196,049 shares in the last quarter. BlackRock Inc. grew its stake in shares of HCP by 1.3% during the first quarter. BlackRock Inc. now owns 46,737,345 shares of the real estate investment trust’s stock worth $1,462,881,000 after buying an additional 591,173 shares during the last quarter. Cohen & Steers Inc. lifted its holdings in HCP by 35.0% in the fourth quarter. Cohen & Steers Inc. now owns 22,898,362 shares of the real estate investment trust’s stock valued at $639,551,000 after buying an additional 5,935,752 shares during the period. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in HCP by 73.8% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,036,864 shares of the real estate investment trust’s stock valued at $392,050,000 after buying an additional 5,960,734 shares during the period. Finally, JPMorgan Chase & Co. lifted its holdings in HCP by 5.4% in the first quarter. JPMorgan Chase & Co. now owns 11,420,161 shares of the real estate investment trust’s stock valued at $357,451,000 after buying an additional 581,291 shares during the period. Institutional investors own 95.51% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was originally published by Watch List News and is the property of of Watch List News. If you are accessing this report on another website, it was copied illegally and republished in violation of U.S. and international copyright and trademark law. The original version of this report can be accessed at https://www.watchlistnews.com/hcp-nysehcp-hits-new-12-month-high-at-32-29/3041529.html.
About HCP (NYSE:HCP)
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Featured Story: Backdoor Roth IRA
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.